Core Viewpoint - Allient (ALNT) has shown strong stock performance, with a 10.7% increase over the past month and reaching a 52-week high of $61.8, although its year-to-date gain of 13.3% lags behind the broader sector and industry performance [1][2]. Financial Performance - Allient has consistently outperformed earnings expectations, beating the Zacks Consensus Estimate in the last four quarters. In the latest earnings report on November 5, 2025, the company reported an EPS of $0.59, exceeding the consensus estimate of $0.5, and also surpassed revenue estimates by 3.02% [2]. - For the current fiscal year, Allient is projected to achieve earnings of $2.46 per share on revenues of $544.98 million, with a year-over-year earnings growth of 19%. For the next fiscal year, earnings are expected to rise to $2.86 per share on revenues of $573.88 million, reflecting a 5.3% increase [3]. Valuation Metrics - Allient's current valuation metrics indicate a trading multiple of 24.7X current fiscal year EPS estimates, which is below the peer industry average of 27X. On a trailing cash flow basis, the stock trades at 20.1X compared to the peer group's average of 17.4X, suggesting it is not among the top value stocks [6]. Style Scores and Zacks Rank - Allient holds a Value Score of B, a Growth Score of A, and a Momentum Score of D, resulting in a combined VGM Score of A. The Zacks Rank for Allient is 2 (Buy), supported by a favorable earnings estimate revision trend, indicating potential for further stock appreciation [5][7].

Group 1 - Major indexes experienced a mixed week, with Allient (ALNT) and Wabtec (WAB) reaching new highs, alongside health technology company Penumbra (PEN) trading in or near buy zones [5] - Allient stock has shown a significant turnaround in growth and demand, outperforming all Mag 7 stocks year to date [6] - Wabtec stock has reached a record high, driven by strong profit growth, indicating a bullish signal for the industrial tech sector [8] Group 2 - Oracle's stock jumped following reports that TikTok signed a deal to create a U.S. joint venture, highlighting the impact of strategic partnerships on stock performance [7] - Penumbra is noted for showing improved relative strength, indicating potential for further growth in the health technology sector [10] - Caterpillar is in a buy zone after a recent breakout move, suggesting positive momentum in the Dow Jones stocks [10]

Core Viewpoint - Allient (ALNT), a motion control technology maker, has been recognized on the Investor's Business Daily Breakout Stocks Index and the Stock Spotlight screen, indicating strong market performance and potential for further growth [1] Company Performance - Allient stock has significantly outperformed the Magnificent Seven stocks year to date, which include major companies like Alphabet (GOOGL), Nvidia (NVDA), Tesla (TSLA), and Meta Platforms (META) [1] - The company is positioned to potentially reach another record high in stock performance, suggesting strong investor confidence and market demand for its technology [1]

Core Viewpoint - Growth investors seek stocks with above-average financial growth, but identifying stocks that can fulfill their potential is challenging due to inherent risks and volatility [1] Group 1: Company Overview - Allient (ALNT) is currently recommended as a growth stock by the Zacks Growth Style Score system, which evaluates a company's growth prospects beyond traditional metrics [2] - Allient has a favorable Growth Score and a top Zacks Rank, indicating strong potential for performance [2] Group 2: Earnings Growth - Historical EPS growth for Allient stands at 14.1%, but projected EPS growth for this year is significantly higher at 38.9%, surpassing the industry average of 25.8% [5] Group 3: Asset Utilization - Allient's asset utilization ratio is 0.91, indicating that the company generates $0.91 in sales for every dollar in assets, which is more efficient than the industry average of 0.72 [6] Group 4: Sales Growth - The company's sales are expected to grow by 2.8% this year, compared to an industry average of 0% [7] Group 5: Earnings Estimate Revisions - The current-year earnings estimates for Allient have been revised upward, with the Zacks Consensus Estimate increasing by 2.3% over the past month, indicating positive momentum [9] Group 6: Investment Positioning - Allient has achieved a Growth Score of B and a Zacks Rank 1 due to positive earnings estimate revisions, positioning it well for potential outperformance in the market [11]

Group 1 - The Santa Claus Rally is a significant market phenomenon that investors should be aware of, with resources available to understand its implications [3] - Allient, a company specializing in precision and specialty motion-control components, is showing bullish signals as it approaches a new entry point, indicating potential market leadership [6] - Allient's IBD SmartSelect Composite Rating has improved from 93 to 96, reflecting its strong performance and market position [6][7] Group 2 - Reports indicate that Donald Trump's potential executive order could loosen federal restrictions on marijuana, positively impacting marijuana stocks [8] - Rockwell has exited the buy zone despite an earnings beat, highlighting the volatility in stock performance [9] - Bitcoin mining companies are leading advancements in the healthcare sector, showcasing the intersection of technology and health [11]

Core Viewpoint - Growth investors are focused on identifying stocks with above-average financial growth, which can lead to solid returns, but finding such stocks is challenging due to inherent volatility and risks [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Allient (ALNT) is currently recommended as a strong growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for growth investors, with double-digit growth being highly desirable as it indicates strong future prospects [3] - Allient has a historical EPS growth rate of 14.1%, but projected EPS growth for this year is significantly higher at 38.9%, surpassing the industry average of 26.7% [4] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for growth stocks, reflecting how efficiently a company generates sales from its assets [5] - Allient's S/TA ratio is 0.91, indicating it generates $0.91 in sales for every dollar in assets, which is above the industry average of 0.72 [5] Group 4: Sales Growth - Sales growth is another critical factor, with Allient expected to achieve a sales growth of 2.8% this year, compared to an industry average of 0% [6] Group 5: Earnings Estimate Revisions - Trends in earnings estimate revisions are correlated with stock price movements, and Allient has seen a positive trend with current-year earnings estimates rising by 5.4% over the past month [7] Group 6: Overall Positioning - Allient has earned a Growth Score of B and holds a Zacks Rank 1 due to positive earnings estimate revisions, positioning it well for potential outperformance [9]

Market Overview - U.S. stocks have shown resilience, maintaining a strong upswing despite volatility, with major indexes near record levels supported by robust corporate earnings and investor appetite [1][2] - The end of the government shutdown has alleviated concerns, allowing for a more optimistic outlook on gradual policy easing from the Federal Reserve [2] Investment Strategy - A relative price strength strategy is recommended, focusing on stocks that outperform the market even during pauses, which helps investors align with market leadership [3][4] - Stocks that exceed their industry or benchmark performance should be prioritized for inclusion in investment portfolios, as they are more likely to yield significant returns [5] Stock Screening Criteria - Stocks should demonstrate positive relative price changes over 1, 4, and 12 weeks, outperforming the S&P 500 [8] - The screening highlights five stocks with strong relative price strength amid market gains, including Par Pacific Holdings, AngloGold Ashanti, Globus Medical, Allient Inc., and Sandisk Corporation [8] Company Highlights - **Par Pacific Holdings (PARR)**: Market cap of $2.2 billion, with a 146.2% share gain over the past year and a 112.3% increase in 2025 earnings estimates [11][8] - **AngloGold Ashanti (AU)**: Market cap over $33 billion, with a 220% share gain in the past year and a 162.4% year-over-year growth in 2025 earnings estimates [12][11] - **Globus Medical (GMED)**: Expected EPS growth rate of 14.3%, with a 3.2% share increase in a year and a positive revision in earnings estimates [13][14] - **Allient Inc. (ALNT)**: Market cap nearly $900 million, with a 117.7% share gain in a year and a 5.2% increase in 2025 earnings estimates [15][16] - **Sandisk Corporation (SNDK)**: Market cap of $37.3 billion, with a 422.9% share gain in a year and a 308% growth in fiscal 2026 earnings estimates [17][18]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates is challenging due to inherent risks and volatility [1] Group 1: Company Overview - Allient (ALNT) is currently highlighted as a recommended growth stock by the Zacks Growth Style Score system, which evaluates a company's growth prospects beyond traditional metrics [2] - The company has a favorable Growth Score and a top Zacks Rank, indicating strong potential for performance [2] Group 2: Earnings Growth - Allient's historical EPS growth rate stands at 14.1%, but the projected EPS growth for this year is significantly higher at 34%, surpassing the industry average of 20.2% [5] Group 3: Asset Utilization - Allient's asset utilization ratio (sales-to-total-assets ratio) is 0.91, indicating that the company generates $0.91 in sales for every dollar in assets, which is above the industry average of 0.72 [6] Group 4: Sales Growth - The company's sales are expected to grow by 1.6% this year, while the industry average is stagnant at 0% [7] Group 5: Earnings Estimate Revisions - The current-year earnings estimates for Allient have been revised upward, with the Zacks Consensus Estimate increasing by 4% over the past month, indicating positive momentum [9] Group 6: Conclusion - Allient has achieved a Zacks Rank 1 and a Growth Score of B, suggesting it is a strong candidate for growth investors and has the potential to outperform [11]

Core Insights - Allient reported Q3 CY2025 results exceeding market expectations, with revenue of $138.7 million, reflecting a year-on-year growth of 10.8% and surpassing analyst estimates by 3.4% [1][6] - The non-GAAP profit was $0.59 per share, which is 20.4% above analysts' consensus estimates of $0.49 [1][6] - Despite strong performance, the market reacted negatively, attributed to ongoing softness in mobility solutions and a significant defense contract cancellation affecting backlog quality [3][4] Revenue and Profitability - Revenue reached $138.7 million, exceeding analyst estimates of $134.2 million [6] - Adjusted EPS was $0.59, beating analyst estimates of $0.49 by 20.4% [6] - Adjusted EBITDA stood at $20.3 million, with a margin of 14.6%, surpassing estimates by 15.9% [6] - Operating margin improved to 9.4%, up from 5.5% in the same quarter last year [6] Market Segments - The industrial segment was the largest contributor, driven by strong demand for power quality solutions in data centers, offsetting weaknesses in oil and gas [7] - Medical revenue grew, particularly in surgical instruments, while mobility solutions continued to show softness [8] - The vehicle business stabilized, with improvements in commercial automotive and construction sectors, while exposure to powersports was reduced to below 10% of revenue [8] Operational Efficiency - Gross margin reached a record 33.3%, attributed to ongoing operational improvements and a shift towards higher-margin programs [7] - The company's Simplify to Accelerate Now initiative contributed to margin expansion and operational efficiency [5][7] - The transition of the Dothan facility is expected to yield further cost savings as it becomes a fabrication center of excellence [7] Future Outlook - Management expressed confidence in sustaining margin expansion and cash generation through operational discipline and targeted growth in high-value markets [4] - Key trends such as electrification, automation, and digital infrastructure are central to Allient's strategy [4] - Ongoing efforts to address tariff-related challenges and secure supply chains are prioritized for the upcoming quarters [4]

Core Insights - Allient's shares dropped 11.2% following the cancellation of the M10 Booker Tank program by the U.S. Army, which raised concerns about future business in its Aerospace & Defense division [1] - The company reported a book-to-bill ratio of 0.96, indicating that it received fewer orders than it filled, suggesting a potential slowdown in demand [1] - Despite achieving double-digit revenue growth and a record gross margin, the loss of the defense contract overshadowed these positive results [1] Market Reaction - Allient's stock has shown significant volatility, with 21 moves greater than 5% in the past year, indicating that the recent news has greatly affected market perception [3] - The previous notable stock movement occurred when shares gained 6% after the announcement of the Pyxmos™ Servo Drive, highlighting the company's focus on innovation and performance in motion systems [4] Financial Performance - Year-to-date, Allient's stock is up 104%, but it is currently trading 11.8% below its 52-week high of $56.69 [5] - An investment of $1,000 in Allient's shares five years ago would now be worth $1,873, reflecting strong long-term growth despite recent volatility [5]